The presence of inflammatory bowel disease conveys increased risk of comorbid nonalcoholic fatty liver disease, nonalcoholic steatohepatitis and nonalcoholic cirrhosis, two new Cleveland Clinic epidemiological studies show.
Miguel Regueiro, MD, Chair of Cleveland Clinic’s Department of Gastroenterology, Hepatology and Nutrition, highlights six can’t-miss DDW presentations by our researchers.
If you’re looking for the latest insights and leading-edge information on IBD and gastrointestinal endoscopy, you’ll want to attend these upcoming Cleveland Clinic CME events.
Cleveland Clinic colorectal surgeon Amy Lightner, MD, a leading translational researcher and clinical trials director, talks about stem cells’ potential to improve IBD management.
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services Policy
A study presented at ACG 2018 today is the first to show endoscopic balloon dilationis most effective in Crohn’s disease patients with fewer strictures.
Are immune cells really the central players in the development of intestinal strictures in patients with Crohn’s disease? A cross-departmental team received a new Co-Laboratories Award to investigate another hypothesis.
A temporary ileostomy may mitigate complications from an anastomotic leak. Learn how a unique model and score can help predict leak risk in Crohn’s patients, indicating when an ileostomy should be used.
This case outlines a comprehensive workup for a complicated case of abdominal pain and bloody diarrhea. What is the correct diagnosis for this 32-year-old woman?
Cleveland Clinic colorectal surgeons are among the nation’s most experienced in reoperative, complex cases. Discover how our team can help your patients.